Apr 23, 2024 · The recommended dosage of Avsola is 5 mg/kg given as an intravenous induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 5 mg/kg every 8 weeks thereafter for the treatment of adult patients with moderately to severely active ulcerative colitis.

Patients with moderate or severe heart failure taking infliximab (≤5 mg/kg) or patients with mild heart failure should be closely monitored and treatment should be discontinued if new or worsening symptoms appear.

AVSOLA ® is a biosimilar of the biologic medicine Remicade ® (infliximab). Your doctor may prescribe AVSOLA ® to treat your chronic inflammation disease. A biosimilar is a highly similar version of an approved biologic medicine. Biologics …

Oct 31, 2024 · The recommended dosage of AVSOLA is 5 mg/kg given as an intravenous induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 5 mg/kg every 8 weeks thereafter for the treatment of PsA. AVSOLA can be used with or without methotrexate.

The recommended dosage of AVSOLA is 5 mg/kg given as an intravenous induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 5 mg/kg every 8 weeks thereafter for the treatment of adults with moderately to severely active CD or fistulizing CD.

Oct 11, 2024 · Avsola’s dosage in adults with ankylosing spondylitis is based on body weight in kilograms. For your first three infusions, the dosage is 5 mg/kg given at weeks 0, 2, and 6.

The recommended dosage of AVSOLA in adult patients is 5 mg/kg given as an intravenous induction regimen at 0, 2 and 6 weeks followed by a maintenance regimen of 5 mg/kg every 8 weeks thereafter for the treatment of chronic severe (i.e., extensive and/or disabling) Ps.

Jan 7, 2025 · Avsola prevents disease in transgenic mice that develop polyarthritis as a result of constitutive expression of human TNFα, and when administered after disease onset, allows eroded joints to heal. Avsola disrupts the activation of pro-inflammaory cascade signalling.

AVSOLA ® is indicated for: Crohn’s Disease: Reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an... Read more. An Amgen biosimilar to Remicade®. AVSOLA ® is FDA-approved for the same indications as Remicade ®. 1.

Oct 25, 2021 · Avsola (infliximab-axxq) is a prescription injection that treats certain autoimmune diseases in adults and children. Learn about side effects, dosage, and more.